Personal information

No personal information available

Activities

Collapse all

Works (5)

SIRT1: Harnessing multiple pathways to hinder NAFLD

Pharmacological Research
2024 | Journal article
DOI: 10.1016/J.PHRS.2024.107155
WOSUID: WOS:001215564800001
Contributors: Tian, Cheng; Huang, Rongrong; Xiang, Ming
Source: check_circle
Web of Science Researcher Profile Sync

CARD9 deficiency promotes pancreatic cancer growth by blocking dendritic cell maturation via SLC6A8-mediated creatine transport

OncoImmunology
2023 | Journal article
DOI: 10.1080/2162402X.2023.2204015
WOSUID: WOS:000970652700001
Contributors: Tian, Cheng; Yuan, Huimin; Lu, Yi; He, Henghui; Li, Qing; Li, Senlin; Yang, Jian; Wang, Mengheng; Xu, Ruochen; Liu, Qian et al.
Source: check_circle
Web of Science Researcher Profile Sync
grade
Preferred source (of 2)‎

Kinsenoside attenuates liver fibro-inflammation by suppressing dendritic cells via the PI3K-AKT-FoxO1 pathway

Pharmacological Research
2022-03 | Journal article
DOI: 10.1016/j.phrs.2022.106092
Part of ISSN: 1043-6618
Contributors: Ming Xiang; Tingting Liu; Cheng Tian; Kun Ma; Jing Gou; Rongrong Huang; Senlin Li; Qing Li; Chuanrui Xu; Lei Li et al.
Source: Self-asserted source
Cheng Tian
grade
Preferred source (of 2)‎

Therapeutic Agents Against COVID-19 with Clinical Evidence

Current Pharmaceutical Design
2021-04 | Journal article
DOI: 10.2174/1381612827666210114150951
Contributors: Cheng Tian; Ming Xiang
Source: check_circle
Crossref

The Role of CARD9 in Metabolic Diseases

Current Medical Science
2020-04 | Journal article
DOI: 10.1007/s11596-020-2166-4
Part of ISSN: 2096-5230
Part of ISSN: 2523-899X
Source: Self-asserted source
Cheng Tian
grade
Preferred source (of 2)‎
How many people are using ORCID?